RecruitingNCT06767605
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
Registro Español de Enfermedades Hepáticas Colestásicas y Autoinmunes (ColHai)
Sponsor
Asociación Española para el Estudio del Hígado
Enrollment
5,000 participants
Start Date
Jan 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the registry is to know the status of primary biliary colgantis, autoimmune hepatitis, primary sclerosing cholagitis and genetic cholestatic diseases in Spain.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease
Exclusion Criteria1
- Refusal to sign the informed consent for the study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06767605
Related Trials
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
NCT06016842177 locations
A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction
NCT0730484336 locations
Biochemical Response and Clinical Outcomes in Patients With PBC
NCT074497931 location
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
NCT067551511 location
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
NCT067555411 location